565 related articles for article (PubMed ID: 33644908)
1. Engineered Extracellular Vesicles for Cancer Therapy.
Zhang X; Zhang H; Gu J; Zhang J; Shi H; Qian H; Wang D; Xu W; Pan J; Santos HA
Adv Mater; 2021 Apr; 33(14):e2005709. PubMed ID: 33644908
[TBL] [Abstract][Full Text] [Related]
2. Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy.
Sun Y; Sun F; Xu W; Qian H
Tissue Eng Regen Med; 2023 Apr; 20(2):157-175. PubMed ID: 36637750
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles in cancer therapy: Roles, potential application, and challenges.
Liu T; Sun L; Ji Y; Zhu W
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189101. PubMed ID: 38608963
[TBL] [Abstract][Full Text] [Related]
4. Native and engineered extracellular vesicles for wound healing.
Lu S; Lu L; Liu Y; Li Z; Fang Y; Chen Z; Zhou J
Front Bioeng Biotechnol; 2022; 10():1053217. PubMed ID: 36568307
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification.
Liu Q; Li D; Pan X; Liang Y
J Nanobiotechnology; 2023 Sep; 21(1):334. PubMed ID: 37717008
[TBL] [Abstract][Full Text] [Related]
6. Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy.
Tang Y; Liu X; Sun M; Xiong S; Xiao N; Li J; He X; Xie J
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514088
[TBL] [Abstract][Full Text] [Related]
7. Advances in Extracellular Vesicle Nanotechnology for Precision Theranostics.
Wu Q; Fu S; Xiao H; Du J; Cheng F; Wan S; Zhu H; Li D; Peng F; Ding X; Wang L
Adv Sci (Weinh); 2023 Jan; 10(3):e2204814. PubMed ID: 36373730
[TBL] [Abstract][Full Text] [Related]
8. Engineered extracellular vesicles and their mimetics for cancer immunotherapy.
Liu C; Wang Y; Li L; He D; Chi J; Li Q; Wu Y; Zhao Y; Zhang S; Wang L; Fan Z; Liao Y
J Control Release; 2022 Sep; 349():679-698. PubMed ID: 35878728
[TBL] [Abstract][Full Text] [Related]
9. Engineered extracellular vesicles: A novel platform for cancer combination therapy and cancer immunotherapy.
Ahmadi M; Hassanpour M; Rezaie J
Life Sci; 2022 Nov; 308():120935. PubMed ID: 36075472
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell-Derived Extracellular Vesicles for Cancer Therapy and Tissue Engineering Applications.
Lee CS; Lee M; Na K; Hwang HS
Mol Pharm; 2023 Nov; 20(11):5278-5311. PubMed ID: 37867343
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in therapeutic engineered extracellular vesicles.
Yao C; Zhang H; Wang C
Nanoscale; 2024 Apr; 16(16):7825-7840. PubMed ID: 38533676
[TBL] [Abstract][Full Text] [Related]
12. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
Nasiri Kenari A; Cheng L; Hill AF
Methods; 2020 May; 177():103-113. PubMed ID: 31917274
[TBL] [Abstract][Full Text] [Related]
13. Engineered Extracellular Vesicles: Emerging Therapeutic Strategies for Translational Applications.
Ziegler JN; Tian C
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894887
[TBL] [Abstract][Full Text] [Related]
14. Engineered extracellular vesicles as therapeutics of degenerative orthopedic diseases.
Wei J; Ou Z; Tong B; Liao Z; Yang C
Front Bioeng Biotechnol; 2023; 11():1162263. PubMed ID: 37362216
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
16. Application of engineered extracellular vesicles for targeted tumor therapy.
Zhang F; Guo J; Zhang Z; Duan M; Wang G; Qian Y; Zhao H; Yang Z; Jiang X
J Biomed Sci; 2022 Feb; 29(1):14. PubMed ID: 35189894
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of extracellular vesicles in retinal diseases.
Sun F; Xu W; Qian H
Am J Transl Res; 2021; 13(12):13227-13245. PubMed ID: 35035672
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
[TBL] [Abstract][Full Text] [Related]
19. Genetically engineered cell-derived nanovesicles for cancer immunotherapy.
He S; Zhao Z
Nanoscale; 2024 May; 16(17):8317-8334. PubMed ID: 38592744
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming extracellular vesicles with engineered proteins.
Shi X; Cheng Q; Zhang Y
Methods; 2020 May; 177():95-102. PubMed ID: 31568822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
